UnitedHealth Group Incorporated (UNH)
Automate Your Wheel Strategy on UNH
With Tiblio's Option Bot, you can configure your own wheel strategy including UNH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol UNH
- Rev/Share 479.25
- Book/Share 116.5341
- PB 3.1273
- Debt/Equity 0.8366
- CurrentRatio 0.8229
- ROIC 0.1051
- MktCap 298845219124.0
- FreeCF/Share 19.1322
- PFCF 17.2027
- PE 17.031
- Debt/Assets 0.2542
- DivYield 0.0261
- ROE 0.186
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | UNH | Deutsche Bank | Buy | Hold | -- | $333 | Oct. 29, 2025 |
| Initiation | UNH | Goldman | -- | Buy | -- | $406 | Oct. 14, 2025 |
| Downgrade | UNH | Robert W. Baird | Neutral | Underperform | -- | $198 | July 31, 2025 |
| Reiterated | UNH | Oppenheimer | -- | Outperform | $400 | $325 | July 30, 2025 |
| Downgrade | UNH | Robert W. Baird | Outperform | Neutral | -- | $312 | June 11, 2025 |
| Downgrade | UNH | HSBC Securities | Hold | Reduce | -- | $270 | May 21, 2025 |
| Downgrade | UNH | TD Cowen | Buy | Hold | -- | $308 | May 19, 2025 |
| Downgrade | UNH | BofA Securities | Buy | Neutral | -- | $350 | May 14, 2025 |
| Downgrade | UNH | Raymond James | Strong Buy | Market Perform | -- | -- | May 14, 2025 |
| Downgrade | UNH | HSBC Securities | Buy | Hold | -- | $490 | April 22, 2025 |
News
UnitedHealth Q3 Earnings Beat on Rising Commercial Membership
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH's Q3 earnings beat estimates on solid commercial membership gains and Optum Rx strength, though profits fall sharply on rising medical costs.
Read More
You Can Spell UnitedHealth Without AI
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth delivered a Q3 double beat and raised full-year guidance, signaling improving cost efficiency despite ongoing sector-wide margin pressures. UNH remains undervalued due to sector headwinds and lack of AI narrative, yet its scale, pricing power, and resilient business model offer long-term upside. Optum's restructuring and disciplined capital management position UNH for margin restoration and sustainable growth, with operational gains already visible.
Read More
UnitedHealth: Great News, Finally
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated delivered strong Q3 results, beating both revenue and earnings estimates and raising guidance, signaling a potential turnaround. UNH reported 12% year-over-year revenue growth and a 4% earnings per share beat, reversing a trend of recent estimate misses. The stock has outperformed the market recently, returning 22% in under three months compared to the S&P 500's 7% gain.
Read More
UnitedHealth's Q3 earnings report shows turnaround efforts are gaining steam
Published: October 28, 2025 by: Fast Company
Sentiment: Positive
UnitedHealth on Tuesday raised its annual profit forecast and said it aims to grow in 2026, in a sign that the turnaround efforts under new CEO Stephen Hemsley were gaining steam.
Read More
UnitedHealth Earnings Top Expectations, as Insurer Works Toward a Turnaround
Published: October 28, 2025 by: Investopedia
Sentiment: Positive
America's biggest insurer is showing some signs of improvement in the health of its business, after a series of setbacks.
Read More
UnitedHealth Group Incorporated (UNH) Q3 2025 Earnings Call Transcript
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group Incorporated (NYSE:UNH ) Q3 2025 Earnings Call October 28, 2025 8:00 AM EDT Company Participants Stephen Hemsley - CEO & Non-Independent Non-Executive Chairman Timothy Noel - Chief Executive Officer of UnitedHealthcare Business Patrick Conway - Chief Executive Officer of Optum Rx Wayne DeVeydt - Chief Financial Officer Krista Nelson - Chief Executive Officer of UnitedHealthcare Community & State Sandeep Dadlani - Executive VP and Chief Digital & Technology Officer Robert Hunter Dan Schumacher - President Conference Call Participants Joshua Raskin - Nephron Research LLC Albert Rice - UBS Investment Bank, Research Division Justin Lake - Wolfe Research, LLC …
Read More
UnitedHealth Boosts Guidance And Eyes Big 2026
Published: October 28, 2025 by: 24/7 Wall Street
Sentiment: Positive
UnitedHealth beat EPS expectations and raised full-year guidance, signaling early signs of stabilization.
Read More
UnitedHealth raises full-year guidance as Q3 earnings beat estimates
Published: October 28, 2025 by: Proactive Investors
Sentiment: Positive
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) reported third-quarter revenue and adjusted earnings per share that beat Wall Street expectations, driven by growth in its health benefits and pharmacy services, and raised its full-year guidance. Revenue rose 12% from a year earlier to $113.2 billion, narrowly above analysts' estimate of $113.16 billion.
Read More
Insurance Stock Drifts Lower After Revenue Miss
Published: October 28, 2025 by: Schaeffers Research
Sentiment: Negative
Shares of UnitedHealth Group Inc (NYSE:UNH) were last seen down 0.5% to trade at $364.11, after the company announced third-quarter results of $2.92 per share on $113.2 billion in revenue, the former beating estimates and the latter falling short.
Read More
UnitedHealth: Nothing Is Over
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated delivered Q3 revenue of $113.2 billion, up 12.3% year-over-year, slightly ahead of consensus estimates despite ongoing regulatory and cost challenges. UNH's Q3 EPS of $2.92 beat expectations, signaling stabilization, while the medical care ratio remained elevated at 89.9% but in line with forecasts. Management raised 2025 guidance, expecting adjusted EPS of at least $16.25 and total revenues around $447 billion, with Optum Rx as a key growth driver.
Read More
UnitedHealth (UNH) Reports Q3 Earnings: What Key Metrics Have to Say
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
UnitedHealth Q3: The Falling Knife Has Finally Stopped Falling
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated delivered strong Q3 2025 results, beating expectations, raising guidance, and stabilizing key metrics after a challenging year. UNH's medical care ratio aligned with guidance, revenue grew 12.3% year over year, and both insurance and Optum segments showed solid performance. Investor sentiment has shifted positively, with UNH stock outperforming peers and now trading above average analyst price targets, sparking potential upgrades.
Read More
United Health Jumps After Big Q3 Earnings
Published: October 28, 2025 by: 24/7 Wall Street
Sentiment: Negative
EPS beat by $0.10, but operating income plunged 50% year-over-year to $4.3B.
Read More
UnitedHealth Vs. Centene: Next Week's Q3 Earnings Should Trigger Gains For Both
Published: October 24, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated and Centene Corporation remain heavily discounted after recent selloffs, but are poised for recovery ahead of Q3 earnings. Both UNH and CNC withdrew guidance in 2025 due to rising healthcare utilization and margin pressure, but recent signals suggest stabilization and improving outlooks. CMS's commitment to higher Medicare Advantage rates in 2026 and improving Medicaid margins supports a bullish stance on both stocks.
Read More
UnitedHealth Recovers Its Rhythm Before Q3 Earnings: Time to Buy?
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH's Q3 results hinge on premium growth and Optum gains amid rising costs and margin pressure.
Read More
What Analyst Projections for Key Metrics Reveal About UnitedHealth (UNH) Q3 Earnings
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for UnitedHealth (UNH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Read More
What's Behind The 30% Surge In UNH Stock?
Published: October 23, 2025 by: Forbes
Sentiment: Positive
UnitedHealth (UNH)'s stock jumped 31% in three months, driven not only by a slight increase in revenue and a high P/E multiple, but also amid mixed signals: a Q2 earnings miss, regulatory scrutiny, and renewed investments in AI. What's behind this volatility?
Read More
UNH vs. HUM: Which Healthcare Stock is the Healthier Buy Now?
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
Humana's sharper Medicare focus, cost discipline and leaner structure position it ahead of UnitedHealth in the healthcare stock race.
Read More
UnitedHealth: Bargaining Power And Tariff-Driven Generics Could Improve Margins
Published: October 17, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth: Bargaining Power And Tariff-Driven Generics Could Improve Margins
Read More
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Is It Too Late to Buy UnitedHealth Stock?
Published: October 10, 2025 by: The Motley Fool
Sentiment: Positive
UnitedHealth (UNH -0.10%) shares are up significantly since I upgraded the stock to a buy rating.
Read More
Can Digital Workflows at Optum Rx Transform UNH's Patient Experience?
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
UnitedHealth drives a digital overhaul at Optum Rx, automating pharmacy workflows to boost efficiency and enrich patient care.
Read More
UNITEDHEALTH ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into UnitedHealth Group Incorporated on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Published: October 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In UnitedHealth (UNH) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in UnitedHealth between March 14, 2022, and February 27, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Read More
The Zacks Analyst Blog Tesla, UnitedHealth, Shopify and Waterstone Financial
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
Tesla's robotaxi launch, UnitedHealth's cost challenges, and Shopify's AI-driven merchant tools headline Zacks' latest research roundup.
Read More
UnitedHealth's stock has the potential for a nice pop post-earnings: G Squared's Victoria Greene
Published: October 07, 2025 by: CNBC Television
Sentiment: Positive
Victoria Greene, G Squared Private Wealth, joins 'The Exchange' to discuss which stock could be poised for a bounce around earnings season, the bank Greene is focused on and much more.
Read More
UnitedHealth Jumps 12% in a Month: But is it Healthy Enough to Buy?
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
UnitedHealth Group Incorporated UNH has staged a sharp comeback, with shares climbing 12% over the past month, trimming its year-to-date loss to 29.1%. The move marks an outperformance versus both the broader industry's 9.3% gain and the S&P 500 Index's 4% rise during the same period.
Read More
Billionaires Are Piling Into United Health Group and These 2 Stocks
Published: October 07, 2025 by: 24/7 Wall Street
Sentiment: Neutral
UnitedHealth Group (NYSE:UNH ), Bristol-Myers Squibb (NYSE:BMY) and Fiserv (NYSE:FI) have been getting plenty of attention from big name investors.
Read More
How to trade the health care break out
Published: October 06, 2025 by: CNBC Television
Sentiment: Positive
The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.
Read More
UNH Stock: The $76 Billion Shareholder Powerhouse
Published: October 06, 2025 by: Forbes
Sentiment: Positive
Over the past decade, UnitedHealth (NYSE: UNH) has delivered a remarkable $76 billion back to its shareholders via cash in the form of dividends and buybacks. Despite facing significant headwinds in 2025, the healthcare giant has demonstrated its resilience with the stock showing recent momentum, gaining 12% over the past month, though it remains down -29% year-to-date due to earlier challenges.
Read More
Nesbitt: Economy Remains Strong, Bull Case for UNH, LEVI & VLO
Published: October 03, 2025 by: Schwab Network
Sentiment: Positive
Don Nesbitt sees the economy staying strong even as cracks in the labor force appear to widen. However, he doesn't see the stock market moving significantly higher given current valuations, nor does Don expect interest rates to add momentum at current levels.
Read More
About UnitedHealth Group Incorporated (UNH)
- IPO Date 1984-10-17
- Website https://www.unitedhealthgroup.com
- Industry Medical - Healthcare Plans
- CEO Stephen J. Hemsley
- Employees 400000